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ABSTRACT: Hypervalent tellurium compounds (telluranes)
are promising therapeutical agents with negligible toxicities for
some diseases in animal models. The C−Te bond of
organotellurium compounds is commonly considered unstable,
disfavoring their applicability in biological studies. In this
study, the stability of a set of telluranes composed of an
inorganic derivative and noncharged and charged organic
derivatives was monitored in aqueous media with 1H, 13C, and
125Te NMR spectroscopy and high-resolution mass spectrom-
etry. Organic telluranes were found to be remarkably resistant
and stable to hydrolysis, whereas the inorganic tellurane
AS101 is totally converted to the hydrolysis product,
trichlorooxytellurate, [TeOCl3]
−, which was also observed in the hydrolysis of TeCl4. The noteworthy stability of
organotelluranes in aqueous media makes them prone to further structure−activity relationship studies and to be considered for
broad biological investigations.
■ INTRODUCTION
Tellurium is a rare element narrowly studied in a biological
context. A general belief that all its compounds are toxic impairs
interest in further exploring their biological activities and
applications in therapy. Although toxicity data of elemental
tellurium, tellurite, and tellurate are known,1 only a few organic
tellurides and ditellurides were studied in this context.2 In
contrast to this, there are therapeutically promising examples of
inorganic and organic tellurium compounds showing reduced
toxicity and potent activities in both in vitro and in vivo
models.2−4 The most studied tellurium-containing compound
is the inorganic tellurane named AS101, an ammonium
tellurate, which presents immunomodulatory action3 and was
found to be active in preclinical and clinical studies.4 In addition
to the known cellular pathways modulated by AS101, the high
affinity of the hypervalent tellurium atom with thiols consists
the molecular basis of its effects. This affinity was demonstrated
by NMR studies of AS101 with cysteine and in the inhibition of
cysteine-based proteases (papain and pig spleen cathepsin B)
by Albeck and co-workers in 1998.5 In the following, we have
shown that organic derivatives of tellurium(IV), having ligands
prone to exchange-type reactions, were very potent inhibitors
of recombinant human cathepsin B, up to 40-fold in the relative
second-order Cat.B inhibition rate constants (ki/Ki) compared
to AS101.6 After that, the inhibitions of recombinant human
cathepsins B, L, S, and K were determined for an expanded set
of diverse organotelluranes, including the inorganic derivatives
AS101, a brominated AS101 derivative, and benzyltriethylam-
monium hexachlorotellurate.7 These studies have shown that
the inhibition potency is modulated by the organic moieties
and by the exchangeable ligands bonded to the tellurium atom.
The influence of halides (chloride and bromide) on the
inhibition of cathepsins V and S for a structurally related set of
organotelluranes showed that the bromides were always more
reactive than the chlorides because they led to higher ki/Ki
values, and the corresponding selenuranes were less reactive
than the tellurium homologues but showed the same trend as
the halides.8 It was found that organotelluranes are able to
inhibit tyrosine phosphatases,9 the β2 site of proteasome
(trypsin-like activity),10 to promote the intracellular proteolysis
in Plasmodium falciparum trophozoites,11 to impair the
bioenergetics of mitochondria elicited by thiol consumption,
and to induce the assembly and opening of mitochondrial
permeability transition pore12 and, like AS101, have shown
negligible toxicity for animal models so far. Additional activities
include in vitro antiviral,13 antitumoral,14 and the in vivo
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protection of rats in pilocarpine-induced epilepsy,15 as well as
antileishmanial action in animal models of cutaneous16 and
visceral leishmaniasis.17
The particular reactivity of telluranes with thiols was
previously studied for a few examples of both inorganic and
organic derivatives in model reactions. Thiol consumption in
such reactions was followed by colorimetric assays5−7 and by
125Te NMR spectroscopy,6,10,18 as changes in chromophores or
in the observed tellurium species involved giving insights about
ongoing processes. As telluranes have been shown to be
promising potential therapeutical agents,2−4,11−17 a primary
concern consists in their behavior, including stability in aqueous
media because hydrolytic products can exhibit distinct reactivity
profiles for bionucleophiles. Recently, it has been shown that
AS101 (1) is hydrolyzed forming a triclorooxytellurate (2),
which is suggested to be the actual inorganic tellurane involved
in AS101 bioactivities (Scheme 1).19 The stabilities of two
organotelluranes in a buffered medium were monitored by
NMR spectroscopy, and both dichloride 3a and dibromide 3b
were converted to the corresponding telluroxide 4 above 60
and 70 °C, respectively, suggesting that those derivatives are
very stable in an aqueous environment (Scheme 1).20
These reports stimulated us to share our results on the
stabilities of a set of telluranes depicted in Chart 1. This
collection has two telluranes (8a and 8b) with a hydroxyl
group, which is coordinated to tellurium, another tellurane 8c
that lacks a strong intramolecular n-donor group, the
ammonium(oxo)trichlorotellurate AS101 (1) and the ammo-
nium tetrachloaryltellurate 7. A systematic study was performed
varying the tellurane, the nature of the solvent, and reaction
temperature. All experiments were monitored by 1H, 13C, and
125Te NMR spectroscopy and mass spectrometry.
■ RESULTS AND DISCUSSION
The organotelluranes were prepared by electrophilic addition
reactions of tellurium tetrachloride 5, under microwave
irradiation, to the corresponding alkynes or anisole.21 Tellurium
tetrachloride was prepared by an improved reaction under
microwave irradiation using elemental tellurium and sulfuryl
chloride.22 AS101 (1) was prepared by refluxing a suspension
of tellurium tetrachloride and an equimolar amount of ethylene
glycol in acetonitrile.23 Tellurium tetrachloride was submitted
to reaction with anisole under microwave irradiation to furnish
p-methoxyphenyltellurium trichloride (6),24 the starting ma-
terial of the organic telluranes. The trichloride 6 was treated
with aqueous hydrogen chloride solution (6 mol/L) followed
by reaction with aqueous ammonium chloride to provide
ammonium (p-methoxyphenyl)tetrachlorotellurate (7) in 93%
yield.25 Finally, the remaining organotelluranes were prepared
by the electrophilic addition reactions of trichloride 6 to the
appropriated alkynes under microwave irradiation (Scheme
2).21
With compounds 5−8 and AS101 in hand, we performed a
systematic study of their stabilities in organic solvents in the
absence and the presence of water. Initially, AS101 was
evaluated in aqueous and alcoholic solutions, as previously
described by Silberman and co-workers.19 A 0.44 mol/L
dimethyl sulfoxide (DMSO)-d6 solution of AS101 was treated
with successive additions of D2O, and 5 min after each addition,
the corresponding 125Te NMR spectra were recorded. Thus, as
2 equiv of D2O were added, two species were detected
resonating at 1680 and 1520 ppm, relative to AS101 and a
hydrolysis product, [TeOCl3]
−, respectively. After this, 10
equiv of D2O were added to the same tube and the signals at
1680 and 1520 ppm were attenuated, whereas a new specie
resonating at 1650 ppm appeared. In a control experiment, a
DMSO-d6 solution of TeCl4 (0.44 mol/L) treated with 1 equiv
of deuterated water led to a tellurium specie, which resonated at
1520 ppm, similarly to what was observed for AS101 solution
strongly supporting the presence of [TeOCl3]
− (Figure 1).
The characterization of these species was further done by
high-resolution mass spectrometry-electrospray ionization
Scheme 1. Reported Conversion of the Inorganic Tellurane
AS101 (A) and Organic Telluranes (B) in Aqueous Media to
Hydrolysis Products and Their 125Te Chemical Shifts
Chart 1. Structures of Studied Telluranes
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(HRMS-ESI-(-)) analyses, where AS101, [TeOCl3]
−, and a
chlorotellurinic acid, [HTeClO2]
−, were detected in the
solution treated with 2 equiv of water (Figure 2A). Other
hydrolysis products were detected when the amount of added
water reached 100 equiv, which led to the formation of
[HTeO2]
− as a majority specie (Figure 2B).
The hydrolytic profile of AS101 observed by us is in
accordance with that reported by Silberman and co-workers.19
The ligand-exchange processes of AS101 were further studied
using propylene glycol and ethanol. The reaction of AS101
with propylene glycol led to a rapid formation of a major specie,
resonating at 1690 ppm, resulting from the transacetalization of
Scheme 2. Synthesis of Telluranes 8a−c, Tellurate 7, and AS101
Figure 1. (1) 125Te NMR spectrum of AS101 in DMSO-d6. (2)
125Te NMR spectrum of AS101 in DMSO-d6 and 2 equiv of D2O. (3)
125Te NMR
spectrum of AS101 in DMSO-d6 and 10 equiv of D2O. (4)
125Te NMR spectrum of TeCl4 in DMSO-d6 and 1 equiv of D2O.
ACS Omega Article
DOI: 10.1021/acsomega.7b00628
ACS Omega 2017, 2, 4431−4439
4433
AS101 to the propylene glycol analogue, as confirmed by the
HSMS-ESI-(-) spectrum (Figure S1).
The reaction of AS101 with ethanol was checked by HRMS-
ESI-(-), where a mixture of AS101 hydrolysis products,
[HTeClO2]
− and [TeOCl3]
−, AS101, and ethoxytetrachlor-
otellurate, [EtOTeCl4]
−, were observed (Figure S2).
To this solution, after the addition of 100 equiv of water, the
total consumption of AS101 as the monoethoxylated tellurate
was suppressed, leading to the same mixture observed by
AS101 hydrolysis (Figure S6). Although this set of experiments
supports the instability of inorganic telluranes, which are prone
to rapid hydrolysis and ligand-exchange reactions, the biological
effects of AS101 and the reactivity of tellurium toward thiols
and related processes are still devoid of clarification.
At this point, we moved our attention to the stability of the
organotelluranes starting with the ammonium tetrachloroaryl
tellurate (7) that exhibited a surprising stability in comparison
to AS101 under identical conditions. The 125Te NMR spectrum
of 4 in DMSO-d6 shows a signal at 1241 ppm relative to the
reference signal of PhTeTePh. The successive addition of 25%
in volume of phosphate-buffered saline (PBS) solution did not
change the HRMS-ESI-(-) and 125Te NMR spectra even after
30 days at 25 °C (Figure 3). The successive addition of D2O to
the DMSO-d6 solution of 7 in a separate experiment also did
not furnish any new specie. These results evidence the higher
stability of the tellurate 7 toward hydrolysis relative to AS101.
The neutral organotelluranes 8a−c were then studied to
check their stability toward an aqueous environment. A control
experiment consisting in a DMSO-d6 (0.26 mol/L) solution of
8a and D2O solution of 8a (90:10 v/v) has been maintained on
the lab bench, and 1H, 13C, and 125Te NMR spectra were
recorded for over 2 years, showing no extent of decomposition
and hydrolysis. This astounding result encouraged us to carry
out further experiments with organotelluranes 8a−c monitoring
possible hydrolysis reactions. All experiments were performed
in NMR tubes containing 0.25 mol/L solutions of compounds
8a−c in a DMSO-d6/D2O (90:10) mixture using diphenyldi-
telluride as an external reference. NMR spectra were recorded
in the course of 30 days (initially on a daily basis for 1 week and
on a weekly basis for 1 month). As shown in the 125Te NMR
spectra, the telluranes 8a−c were remarkably stable toward
hydrolysis in these solutions (Figures 4−6).
In addition to that, the organotellurane 8a was held in a
DMSO-d6/PBS buffer (pH 7.4) mixture and monitored over
the course of 4 days varying the incubation temperatures in
three independent experiments. In the first experiment, the
solution was maintained at 25 °C for 2 h (Figure 7A); in the
second experiment, the solution was incubated at 40 °C for 48
h (Figure 7B). Finally, the solution was incubated at 40 °C for
96 h (Figure 7C). In all cases, the organotellurane 8a remained
intact.
In a further experiment, the stability of compound 8a was
checked in acidic media. In a 5 mm NMR tube, 50 mg of
compound 8a was diluted in a mixture of DMSO-d6 (300 μL)
and HCl (30 μL, 6 mol/L), the solution was maintained at 25
°C for 24 h, and after that time, compound 8a did not show any
transformation. The same behavior was observed in a less acidic
medium composed of a mixture of DMSO-d6 and buffered
acetate solution (pH 5.5). As telluranes react with bases in
known reactions of diorganyl tellurium dichlorides, which are
converted into dihydroxides26 or oxides,27 their stability in basic
media is therefore worrying. Nevertheless, organotellurane 8a
did not resist when challenged in concentrated basic media
using sodium hydroxide (pH 12) it showed a remarkable
persistence at pH 8.0 (sodium phosphate buffer) that was
monitored for 6 days at room temperature.
Figure 2. HRMS-ESI-(-) spectra of AS101 after treated with (A) 2 equiv and (B) 100 equiv of water.
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Taken together, our data demonstrate a striking difference in
the stabilities of inorganic and organic telluranes. As inorganic
telluranes are promptly converted to other species eliminating
their ligands, the organic moieties of organotelluranes are
remarkably persistent in aqueous environments. In an attempt
to gain insight into these differences, we performed density
functional theory calculations. The Gibbs free energies,
collected in Scheme S1 (see Supporting Information), were
used to evaluate the relative stability of the compounds AS101,
7, and 8b against hydrolysis. The computed thermochemistry
indicates that AS101 undergoes hydrolysis more easily than
compounds 7 and 8b because it showed to be less stable than
the other compounds by ∼4 kcal/mol. Also, the charge
distributions in these molecules were obtained using the
Natural Population Analysis (NPA) model (Table S1). In
agreement with the behavior observed in the thermochemistry
results, the NPA charges indicate that the higher negative
charges were observed on the ethylene glycol’s oxygen atoms in
AS101. The NPA showed that tellurium atom presents the
larger positive charges of +1.894 for AS101 and +1.450 and
+1.565 for telluranes 7 and 8b, respectively. These differences
point to a more electrophilic character of AS101’s tellurium
atom than in the organic derivatives that suffer a nucleophilic
attack of water followed by the protonation of alkoxide in a
stepwise mechanism yielding the [TeOCl3]
− specie.
Also, the superior stability of organotelluranes combined
with a higher reactivity for biological thiols7 may explain in part
the high biological activities but might raise concerns about
their clearance from the body. The mechanisms of organo-
tellurium metabolization are not yet clear as for elemental
tellurium and tellurite in plants and some microorganisms. In
this direction, further pharmacokinetics studies are currently
under way to clarify this point. On the other hand, the higher
stability of tellurium organic derivatives prompts their
structure−activity relationship studies due to the persistence
of the organic moieties bonded to tellurium.
■ EXPERIMENTAL SECTION
General Information. Microwave reactions were per-
formed with a CEM Discover Synthesis Unit (CEM Co.,
Matthews, NC), with a continuous focused microwave power
delivery system in a glass vessel (10 or 35 mL) sealed with
Teflon cap, under magnetic stirring. Analytical thin-layer
chromatography for monitoring reactions was performed
using Merck 0.2 mm silica gel 60 F-254 Al plates. NMR
spectra were recorded on a Bruker AC 200 spectrometer
(Bruker BioSpin GmbH, Rheinstetten, Baden-Wurttemberg,
Germany) operating at 200, 50, and 63 MHz for 1H, 13C, and
125Te NMR spectroscopies, respectively. DMSO-d6 was used as
solvent and internal reference, tetramethylsilane for 1H and 13C
NMR spectroscopies, and diphenylditelluride for 125Te NMR
spectroscopy, chemical shifts (δ) are given in parts per million,
and coupling constants (J) are given in hertz (Hz). All reagents
are of commercial grade and were pretreated whenever
required (all reagents were purchased from Sigma-Aldrich
Figure 3. (A) HRMS-ESI-(-) spectrum of compound 7 after 30 days in aqueous solution. (B) 125Te NMR spectrum of compound 7 in DMSO-d6.
(C) 125Te NMR spectrum of compound 7 after 30 days in DMSO-d6 (300 μL) and PBS (100 μL, 1 mol/L).
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Co., St. Louis, MO). Compounds 8a−c, AS101, and organo-
tellurate 7 were prepared as previously described.5,21,25
Exposure Stability Study of Tellurium Tetrachloride in
Water. In a 5 mm NMR tube, 50 mg of 0.37 mmol tellurium
Figure 4. 125Te NMR spectrum of 8a in a DMSO-d6/D2O (90:10) mixture.
Figure 5. 125Te NMR spectrum of 8b in a DMSO-d6/D2O (90:10) mixture.
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Figure 6. 125Te NMR spectrum of 8b in a DMSO-d6/D2O (90:10) mixture.
Figure 7. 125Te NMR spectrum of 8a in a DMSO-d6/PBS buffer (pH 7.4) mixture at (A) 25 °C after 2 h, (B) 40 °C after 48 h, and (C) 40 °C after
96 h.
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tetrachloride was diluted in a 300 μL of DMSO-d6 and then 1
equiv of deuterated water (7.5 μL) was added. A capillary tube
of diphenylditelluride was used as a chemical shift standard.
After 1 h, 125Te NMR spectrum was recorded at 25 °C.
Exposure Stability Study in Water. In a 5 mm NMR
tube, 50 mg of the compound under investigation was diluted
in a mixture of 360 μL of DMSO-d6 and 40 μL of D2O. A
capillary glass tube containing diphenylditelluride was used as a
chemical shift standard. The same sample was maintained for a
period of 30 days in solution in this mixture. The 125Te NMR
spectrum was recorded daily for 7 days and weekly for up to 30
days.
Exposure Stability Study in PBS. In a 5 mm NMR tube,
50 mg of the compound under investigation was diluted in a
mixture of 300 μL of DMSO-d6 and 30 μL of D2O. A capillary
glass tube containing diphenylditelluride was used as a chemical
shift standard. The same sample was maintained for a period of
30 days in this solution and then the 125Te NMR spectrum was
recorded.
Thermal Stability Study. In a 5 mm NMR tube, 50 mg of
the compound under study was diluted in a mixture of 360 μL
of DMSO-d6 and 40 μL of D2O or PBS. A capillary glass tube
containing diphenylditelluride was used as a chemical shift
standard. An initial 125Te NMR spectrum was recorded at 25
°C. The same sample was heated (40 °C) for 24−96 h, and
125Te NMR spectra were recorded.
Exposure Stability Study in Acid Media. In a 5 mm
NMR tube, 50 mg of the compound under study was diluted in
a mixture of 300 μL of DMSO-d6 and 30 μL of HCl (6 mol/L)
or 200 mmol/L sodium acetate buffer (pH 5.5). A capillary
glass tube containing diphenylditelluride was used as a chemical
shift standard. After 24 h, a 125Te NMR spectrum was recorded
at 25 °C.
Theoretical Calculations. All calculations were performed
with the Gaussian 0928 suite of program. The M06L
functional,29 which includes dispersion effects, was used in
this study. The SDD pseudopotential and its associated double
zeta basis set were used for Te, whereas 6-31+G(d,p) basis set
was used for the rest of atoms.30−37 The optimized geometries
were calculated including the solvent effect (water) using the
SMD continuum solvation model.38 All energies reported
herein are Gibbs free energies at 273.15 K and 1 atm. The NPA
model39 was used to determine the charges distributed on the
molecule atoms.
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Tellurium: an element with great biological potency and potencial.
Org. Biomol. Chem. 2010, 8, 4203−4216.
(5) Albeck, A.; Weitman, H.; Sredni, B.; Albeck, M. Tellurium
compounds: selective inhibition of cysteine proteases and model
reaction with thiols. Inorg. Chem. 1998, 37, 1704−1712.
(6) Cunha, R. L. O. R.; Urano, M. E.; Chagas, J. R.; Almeida, P. C.;
Trindade, C. B.; Tersariol, I. L. S.; Comasseto, J. V. Tellurium-based
cysteine protease inhibitors: evaluation of novel organotellurium(IV)
compounds as inhibitors of human cathepsin B. Bioorg. Med. Chem.
Lett. 2005, 15, 755−760.
(7) Cunha, R. L. O. R.; Gouveia, I. E.; Feitosa, G. V. P.; Alves, M. F.;
Bromme, D.; Comasseto, J. V.; Tersariol, I. L. S.; Juliano, L.
Irreversible inhibition of human cathepsins B, L, S and K by
hypervalent tellurium compounds. Biol. Chem. 2009, 390, 1205−1212.
(8) Piovan, L.; Alves, M. F. M.; Juliano, L.; Brömme, D.; Cunha, R. L.
O. R.; Andrade, L. H. Structure−activity relationships of hypervalent
organochalcogenanes as inhibitors of cysteine cathepsins V and S.
Bioorg. Med. Chem. 2011, 19, 2009−2014.
(9) Piovan, L.; Wu, L.; Zhang, Z. Y.; Andrade, L. H. Hypervalent
organochalcogenanes as inhibitors of protein tyrosine phosphatases.
Org. Biomol. Chem. 2011, 9, 1347−1351.
(10) Piovan, L.; Milani, P.; Silva, M. S.; Moraes, P. G.; Demasi, M.;
Andrade, L. H. 20S proteasome as novel biological target for
organochalcogenanes. Eur. J. Med. Chem. 2014, 73, 280−285.
(11) Maluf, S. E. C.; Melo, P. M. S.; Varotti, F. P.; Gazarini, M. L.;
Cunha, R. L. O. R.; Carmona, A. K. Hypervalent organotellurium
compounds as inhibitors of P. falciparum calcium-dependent cysteine
proteases. Parasitol. Int. 2016, 65, 20−22.
(12) (a) Pessoto, F. S.; Faria, P. A.; Cunha, R. L. O. R.; Comasseto, J.
V.; Rodrigues, T.; Nantes, I. L. Organotellurane-promoted mitochon-
drial permeability transition concomitant with membrane lipid
protection against oxidation. Chem. Res. Toxicol. 2007, 20, 1453−
1461. (b) Yokomizo, C. H.; Pessoto, F. S.; Prieto, T.; Cunha, R. L. O.
R.; Nantes, I. L. Effects of Trichlorotelluro-dypnones on Mitochon-
drial Bioenergetics and Their Relationship to the Reactivity with
Protein Thiols. Chem. Res. Toxicol. 2015, 28, 1167−1175.
ACS Omega Article
DOI: 10.1021/acsomega.7b00628
ACS Omega 2017, 2, 4431−4439
4438
(13) Gouvea, I. E.; Santos, J. A. N.; Burlandy, F. M.; Tersariol, I. L.
S.; da Silva, E. E.; Juliano, M. A.; Juliano, L.; Cunha, R. L. O. R.
Poliovirus 3C proteinase inhibition by organotelluranes. Biol. Chem.
2011, 392, 587−591.
(14) Abondanza, T. S.; Oliveira, C. R.; Barbosa, C. M. V.; Pereira, F.
E. G.; Cunha, R. L. O. R.; Caires, A. C. F.; Comasseto, J. V.; Queiroz,
M. L. S.; Valadares, M. C.; Bincoletto, C. Bcl-2 expression and
apoptosis induction in human HL60 leukaemic cells treated with a
novel organotellurium(IV) compound RT-04. Food Chem. Toxicol.
2008, 46, 2540−2545.
(15) Persike, D. S.; Cunha, R. L. O. R.; Juliano, L.; Silva, I. R.; Rosim,
F. E.; Vignoli, T.; Dona, F.; Cavalheiro, E. A.; Fernandes, M. J. S.
Protective effect of the organotelluroxetane RF-07 in pilocarpine-
induced status epilepticus. Neurobiol. Dis. 2008, 31, 120−126.
(16) Lima, C. B. C.; Arrais-Silva, W. W.; Cunha, R. L. O. R.; Giorgio,
S. A Novel Organotellurium Compound (RT-01) as a New
Antileishmanial Agent. Korean J. Parasitol. 2009, 47, 213−218.
(17) Pimentel, I. A. S.; Paladi, C. S.; Katz, S.; Judice, W. A. S.; Cunha,
R. L. O. R.; Barbieŕi, C. L. In Vitro and In Vivo Activity of an Organic
Tellurium Compound on Leishmania (Leishmania) chagasi. PLoS One
2012, 7, No. e48780.
(18) Silberman, A.; Kalechman, Y.; Hirsch, S.; Erlich, Z.; Sredni, B.;
Albeck, A. The Anticancer Activity of Organotelluranes: Potential Role
in Integrin Inactivation. ChemBioChem 2016, 17, 918−927.
(19) Silberman, A.; Albeck, M.; Sredni, B.; Albeck, A. Ligand-
Substitution Reactions of the Tellurium Compound AS-101 in
Physiological Aqueous and Alcoholic Solutions. Inorg. Chem. 2016,
55, 10847−10850.
(20) Silva, M. S.; Andrade, L. H. 77 Se and 125 Te NMR
spectroscopy on a selectivity study of organochalcogenanes with l-
amino acids. Org. Biomol. Chem. 2015, 13, 5924−5929.
(21) Princival, C. R.; Dos Santos, A. A.; Comasseto, J. V. Solventless
and Mild Procedure to Prepare Organotellurium(IV) Compounds
under Microwave Irradiation. J. Braz. Chem. Soc. 2015, 26, 832−836.
(22) Petragnani, N.; Mendes, S. R.; Silveira, C. Tellurium
tetrachloride: an improved method of preparation. Tetrahedron Lett.
2008, 49, 2371−2372.
(23) Albeck, M.; Tamari, T.; Sredni, B. Synthesis and Properties of
Ammonium Trichloro(dioxyethylene-O,O′)tellurate (AS-101). A New
Immunomodulating Compound. Synthesis 1989, 1989, 635−636.
(24) Cunha, R. L. O. R.; Zukerman-Schpector, J.; Caracelli, I.;
Comasseto, J. V. Revisiting the addition reaction of TeCl4 to alkynes:
The crystal structure and docking studies of 1-chloro-2-trichlor-
otelluro-3-phenyl-propen-2-ol. J. Organomet. Chem. 2006, 691, 4807−
4815.
(25) Petragnani, N.; Comasseto, J. V.; Kawano, Y. New anionic
species of tellurium(IV). J. Inorg. Nucl. Chem. 1976, 38, 608−612.
(26) (a) Uemura, S.; Fukuzawa, S. I. New aspects of the telluroxide
elimination: a facile elimination of sec-alkyl phenyl telluroxide leading
to olefins, allylic alcohols, and allylic ethers. J. Am. Chem. Soc. 1983,
105, 2748−2752. (b) Uemura, S.; Fukuzawa, S. I. Oxidation of alkyl
phenyl selenides, tellurides, and telluroxides with meta-chloroperben-
zoic acid for a facile and novel transformation of C-Se and C-Te bonds
to C-O bonds. J. Chem. Soc., Perkin Trans. 1 1985, 471.
(27) (a) Lederer, K. Zur Kenntnis der p-Anisyl-Tellurverbindungen.
Ber. Dtsch. Chem. Ges. 1916, 49, 1076−1082. (b) Morgan, G. T.;
Kellett, R. E. CXL. Interactions of tellurium tetrachloride and aryl alkyl
ethers. Part II. J. Chem. Soc. 1926, 129, 1080. (c) Bergman, J.
Tellurium in Organic Chemistry. 1. Novel synthesis of biaryls.
Tetrahedron 1972, 28, 3323. (d) Ley, S. V.; Meerholz, C. A.; Barton, D.
H. R. Diaryl telluroxides as new mild oxidizing reagents. Tetrahedron
1981, 37, 213−223.
(28) Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.;
Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Petersson, G.
A.; Nakatsuji, H.; Li, X.; Caricato, M.; Marenich, A.; Bloino, J.;
Janesko, B. G.; Gomperts, R.; Mennucci, B.; Hratchian, H. P.; Ortiz, J.
V.; Izmaylov, A. F.; Sonnenberg, J. L.; Williams-Young, D.; Ding, F.;
Lipparini, F.; Egidi, F.; Goings, J.; Peng, B.; Petrone, A.; Henderson,
T.; Ranasinghe, D.; Zakrzewski, V. G.; Gao, J.; Rega, N.; Zheng, G.;
Liang, W.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.;
Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.;
Throssell, K.; Montgomery, J. A., Jr.; Peralta, J. E.; Ogliaro, F.;
Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.;
Keith, T.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.;
Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Millam, J. M.; Klene,
M.; Adamo, C.; Cammi, R.; Ochterski, J. W.; Martin, R. L.;
Morokuma, K.; Farkas, O.; Foresman, J. B.; Fox, D. J. Gaussian 09;
Gaussian, Inc.: Wallingford, CT, 2016.
(29) Zhao, Y.; Truhlar, D. G. A new local density functional for main-
group thermochemistry, transition metal bonding, thermochemical
kinetics, and noncovalent interactions. J. Chem. Phys. 2006, 125,
No. 194101.
(30) Igel-Mann, G.; Stoll, H.; Preuss, H. Pseudopotentials for main
group elements (IIIA through VIIA). Mol. Phys. 1988, 65, 1321−1328.
(31) Bergner, A.; Dolg, M.; Kuechle, W.; Stoll, H.; Preuss, H. Ab-
initio energy-adjusted pseudopotentials for elements of groups 13-17.
Mol. Phys. 1993, 80, 1431−1441.
(32) Francl, M. M.; Pietro, W. J.; Hehre, W. J.; Binkley, J. S.; Gordon,
M. S.; DeFrees, D. J.; Pople, J. A. Self-consistent molecular-orbital
methods. 24. Supplemented small split-valence basis-sets for 2nd-row
elements. J. Chem. Phys. 1982, 77, 3654−3665.
(33) Ditchfield, R.; Hehre, W. J.; Pople, J. A. Self-consistent
molecular-orbital methods. 9. Extended Gaussian-type basis for
molecular-orbital studies of organic molecules. J. Chem. Phys. 1971,
54, 724−728.
(34) Rassolov, V. A.; Pople, J. A.; Ratner, M. A.; Windus, T. L. 6-
31G* basis set for atoms K through Zn. J. Chem. Phys. 1998, 109,
1223−1229.
(35) Hehre, W. J.; Ditchfield, R.; Pople, J. A. Self-consistent
molecular-orbital methods. 12. Further extensions of Gaussian-type
basis sets for use in molecular-orbital studies of organic molecules. J.
Chem. Phys. 1972, 56, 2257−2261.
(36) Francl, M. M.; Pietro, W. J.; Hehre, W. J.; Binkley, J. S.;
DeFrees, D. J.; Pople, J. A.; Gordon, M. S. Self-consistent molecular-
orbital methods. 23. A polarization-type basis set for 2nd-row elements.
J. Chem. Phys. 1982, 77, 3654−3665.
(37) Marenich, A. V.; Cramer, C. J.; Truhlar, D. G. Universal
solvation model based on solute electron density and on a continuum
model of the solvent defined by the bulk dielectric constant and
atomic surface tensions. J. Phys. Chem. B 2009, 113, 6378−6396.
(38) Reed, A. E.; Weinstock, R. B.; Weinhold, F. Natural-population
analysis. J. Chem. Phys. 1985, 83, 735−746.
(39) Glendening, E. D.; Reed, A. E.; Carpenter, J. E.; Weinhold, F.
NBO, version 3.1; University of Wisconsin-Madison, 2017.
ACS Omega Article
DOI: 10.1021/acsomega.7b00628
ACS Omega 2017, 2, 4431−4439
4439
